Literature DB >> 16307770

CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16.

Iwao Kukimoto1, Takamasa Takeuchi, Tadahito Kanda.   

Abstract

The P670 promoter of HPV16 directs transcription of the virus late genes in the differentiating epithelium. We found that CCAAT/enhancer binding protein beta (C/EBPbeta), a key transcription factor that induces the terminal differentiation of keratinocytes, enhanced the P670-driven transcription in transient reporter assays in HeLa cells and human primary keratinocytes, whereas it inhibited, as reported previously, the transcription from the early P97 promoter. An electrophoretic mobility shift analysis identified two binding sites in the upstream region of P670 for a bacterially expressed C/EBPbeta. A chromatin immunoprecipitation analysis demonstrated that C/EBPbeta bound to these sites of the P670 reporter plasmid in HeLa cells. Nucleotide substitutions in these sites in the reporter plasmid abrogated the enhancement by C/EBPbeta in the transient HeLa and keratinocyte assays, indicating that the C/EBPbeta-binding to these sites is required for the enhancement of transcription from P670. These results suggest that C/EBPbeta is involved in enhancing transcription from the P670 during keratinocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307770     DOI: 10.1016/j.virol.2005.10.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding.

Authors:  Tonia R Wooldridge; Laimonis A Laimins
Journal:  Virology       Date:  2008-01-31       Impact factor: 3.616

2.  Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

Authors:  William K Songock; Matthew L Scott; Jason M Bodily
Journal:  Virology       Date:  2017-04-24       Impact factor: 3.616

3.  Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Authors:  Vignesh Gunasekharan; Guylaine Haché; Laimonis Laimins
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway.

Authors:  Brian S Bowser; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

5.  The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle.

Authors:  Jason M Bodily; Kavi P M Mehta; Linda Cruz; Craig Meyers; Laimonis A Laimins
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Human papillomavirus type 16 P670 promoter is negatively regulated by CCAAT displacement protein.

Authors:  Kaori Sato; Takamasa Takeuchi; Iwao Kukimoto; Seiichiro Mori; Toshiharu Yasugi; Tetsu Yano; Yuji Taketani; Tadahito Kanda
Journal:  Virus Genes       Date:  2007-02-01       Impact factor: 2.332

Review 8.  Papillomavirus interaction with cellular chromatin.

Authors:  Jianxin You
Journal:  Biochim Biophys Acta       Date:  2009-09-26

Review 9.  Regulation of the life cycle of HPVs by differentiation and the DNA damage response.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Future Microbiol       Date:  2013-12       Impact factor: 3.165

10.  Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle.

Authors:  Jason M Bodily; Christine Hennigan; Gary A Wrobel; Cynthia M Rodriguez
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.